European Journal of Cancer
Volume 46, Issue 13 , Pages 2381-2388, September 2010

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial☆

  • Galina Velikova

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • Corresponding Author InformationCorresponding author at: St James’s Institute of Oncology, Cancer Research UK Centre, Bexley Wing (Level 4), St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK. Tel.: +44 0113 2067917; fax: +44 0113 2068512.
    • ,
  • Ada Keding

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Clare Harley

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Kim Cocks

      Affiliations

    • Clinical Trials Research Unit, University of Leeds, Clinical Trials Research House, 71–75 Clarendon Road, Leeds LS2 9PH, United Kingdom
    • ,
  • Laura Booth

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Adam B. Smith

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • Centre for Health & Social Care, University of Leeds, Leeds LS2 9LJ, United Kingdom
    • ,
  • Penny Wright

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Peter J. Selby

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • Joint senior authors.
    • ,
  • Julia M. Brown

      Affiliations

    • Clinical Trials Research Unit, University of Leeds, Clinical Trials Research House, 71–75 Clarendon Road, Leeds LS2 9PH, United Kingdom
    • Joint senior authors.

Received 23 December 2009; received in revised form 26 April 2010; accepted 29 April 2010. published online 31 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Presented as oral presentation at the NCRI Cancer Conference, Birmingham, UK, 5th–9th October 2009.

PII: S0959-8049(10)00371-0

doi:10.1016/j.ejca.2010.04.030

European Journal of Cancer
Volume 46, Issue 13 , Pages 2381-2388, September 2010

Article Tools

* Image Usage & Resolution